The deficit syndrome in the DMS-IV Field Trial: I. Alcohol and other drug abuse

Schizophrenia Research

Volumn 20, Issue 1-2, 1996, Pages 69-77

  Kirkpatrick, Brian ^a   Amador, Xavier F ^b   Flaum, Michael ^c   Yale, Scott A ^b   Gorman, Jack M ^b   Carpenter Jr , William T ^a   Tohen, Mauricio ^d   McGlashan, Thomas ^e  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

deficit syndrome; DMS IV; drug abuse; schizophrenia

Indexed keywords

ALCOHOL; AMPHETAMINE; CANNABIS; COCAINE; PHENCYCLIDINE; PSYCHOTROPIC AGENT; STREET DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; PRIORITY JOURNAL; SCHIZOPHRENIA; ADDICTION; ALCOHOLISM; CANNABIS ADDICTION; CLASSIFICATION; COMORBIDITY; EMOTIONAL DISORDER; MIDDLE AGED; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMETRY; REPRODUCIBILITY; RISK FACTOR; STATISTICS; UNITED STATES;

ADULT; AFFECTIVE SYMPTOMS; ALCOHOLISM; COMORBIDITY; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOTROPIC DRUGS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 0030137822     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-9964(95)00102-6     Document Type: Article

References (24)

1. Andreasen, N.C. (1982) Negative symptoms in schizophrenia. Definition and reliability. Arch. Gen. Psychiatry 39, 784-788.
2. Andreasen, N.C. (1984) The Scale for the Assessment of Positive Symptoms (SAPS). The University of Iowa, Iowa City, Iowa.
3. Andreasen, N.C., Flaum, M. and Arndt, S. (1992) The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch. Gen. Psychiatry 49, 615-623.
4. Andreasen, N.C., Arndt, S., Alliger, R., Miller, D. and Flaum, M. (1995) Symptoms of schizophrenia. Methods, meanings, and mechanisms. Arch. Gen. Psychiatry 52, 341-351.
5. Arndt, S., Tyrrell, G., Flaum, M. and Andreasen, N.C. (1992) Comorbidity of substance abuse and schizophrenia: the role of premorbid adjustment. Psychol. Med. 22(2), 379-388.
6. Bartels, S.J., Teague, G.B., Drake, R.E., Clark, R.E. et al. (1993) Substance abuse in schizophrenia: service utilization and costs. J. Nerv. Ment. Dis. 181(4), 227-232.
7. Buchanan, R.W., Kirkpatrick, B., Heinrichs, D.W. and Carpenter, W.T. (1990) Clinical correlates of the deficit syndrome of schizophrenia. Am. J. Psychiatry 147, 290-294.
8. Buckley, P., Thompson, P., Way, L. and Meltzer, H.Y. (1994) Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy. Am. J. Psychiatry 151(3), 385-389.
9. Dixon, L., Haas, G., Weiden, P.J., Sweeney, J. and Frances, A.J. (1991) Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am. J. Psychiatry 148(2), 224-230.
10. Endicott, J., Spitzer, R.L., Fleiss, J.L. and Cohen, J. (1976) The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry 33, 766-771.
11. Fenton, W.S. and McGlashan, T.H. (1991) Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course. Arch. Gen. Psychiatry 48, 978-986.
12. Fenton, W.S. and McGlashan, T.H. (1992) Testing systems for assessment of negative symptoms in schizophrenia. Arch. Gen. Psychiatry 49, 236-237.
13. Flaum, M., Amador, X.F., Bracha, H.S., Edell, W., Gorman, J., Kendler, K., Leiberman, K., McGlashan, T., McGorry, P., Ontiveros, A., Pandurangi, A., Robinson, D. and Tohen, M. (submitted). DSM-IV Field Trial for Schizophrenia and Related Psychotic Disorders.
14. Kirkpatrick, B. and Buchanan, R.W. (1990) Anhedonia and the deficit syndrome of schizophrenia. Psychiatry Res. 31, 25-30.
15. Kirkpatrick, B., Buchanan, R.W., McKenney, P.D., Alphs, L.D. and Carpenter, W.T. Jr. (1989) The schedule for the Deficit Syndrome: an instrument for research in schizophrenia. Psychiatry Res. 30, 119-123.
16. Kirkpatrick, B., Buchanan, R.W., Breier, A. and Carpenter, W.T. Jr. (1993) Case identification and stability of the deficit syndrome of schizophrenia. Psychiatry Res. 47, 47-56.
17. McGlashan, T.H. and Fenton, W.S. (1992) The positive-negative distinction in schizophrenia. Review of natural history validators. Arch. Gen. Psychiatry 49, 63-72.
18. Regier, D.A., Farmer, M.E., Rae, D.S., Locke, B.Z. et al. (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264(19), 2511-2518.
19. Salloum, I.M., Moss, H.B. and Daley, D.C. (1991) Substance abuse and schizophrenia: impediments to optimal care. Am. J. Drug Alcohol Abuse 17(3), 321-336.
20. Sanguineti, V.R. and Samuel, S.E. (1993) Comorbid substance abuse and recovery from acute psychiatric relapse. Hosp. Community Psychiatry 44(11 ), 1073-1076.
21. Soni, S.D. and Brownlee, M. (1991) Alcohol abuse in chronic schizophrenics: implications for management in the community. Acta Psychiatr. Scand. 84(3), 272-276.
22. Soyka, M., Albus, M., Kathmann, N., Finelli, A. et al. (1993) Prevalence of alcohol and drug abuse in schizophrenic inpatients. Eur. Arch. Psychiatry Clin. Neurosci. 242(3), 362-372.
23. Strakowski, S.M., Tohen, M., Flaum, M. and Amador, X. (1994) Substance abuse in psychotic disorders: associations with affective syndromes. Schizophr. Res. 14, 73-81.
24. Zisook, S., Heaton, R., Moranville, J., Kuck, J. et al. (1992) Past substance abuse and clinical course of schizophrenia. Am. J. Psychiatry 149(4), 552-553.